“Sleep Inertia in Idiopathic Hypersomnia or Narcolepsy in a Phase 4 Study”

Wednesday, December 16  at 12:00pm – 1:00pm ET

Overview: Idiopathic hypersomnia and narcolepsy are chronic central disorders of hypersomnolence with debilitating symptoms that impact patients 24-hours a day. In this webinar, we will explore the symptom burden of these sleep disorders, and sleep inertia in particular. We will also discuss innovative approaches for assessing sleep inertia in idiopathic hypersomnia and narcolepsy and explore similarities and differences in the clinical presentation and characteristics of sleep inertia in these patient populations.

Learning Outcomes 

  1. Review the 24-hour symptom burden of idiopathic hypersomnia and narcolepsy
  2. Introduce approved indications and key safety information for a treatment for idiopathic hypersomnia and 2 key symptoms of narcolepsy
  3. Discuss novel methods for evaluating sleep inertia in idiopathic hypersomnia and narcolepsy
  4. Explore sleep inertia findings from a Phase 4 study

Speakers:

Deborah Nichols, M.S.

Director, Clinical Scientist in Neuroscience Medical Affairs at Jazz Pharmaceuticals

Hans P. A. Van Dongen, PhD

Professor, Dept. of Translational Medicine & Physiology, Washington State University Spokane

The SRSF and the SRS do not endorse any products discussed in this session.

Complimentary, Advanced Registration is Required. A recording of the webinar will be available at a later date.